Connection

Brent Egan to Obesity

Back to Details
This is a "connection" page, showing publications Brent Egan has written about Obesity.
Brent Egan
Connection Strength
2.824
Obesity
  1. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences. Ethn Dis. 2015 Nov 05; 25(4):511-4.
    View in: PubMed
    Score: 0.305
  2. Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60.
    View in: PubMed
    Score: 0.252
  3. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46.
    View in: PubMed
    Score: 0.197
  4. Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23.
    View in: PubMed
    Score: 0.165
  5. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic. Arq Bras Cardiol. 2006 Oct; 87(4):538-47.
    View in: PubMed
    Score: 0.162
  6. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
    View in: PubMed
    Score: 0.138
  7. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30.
    View in: PubMed
    Score: 0.126
  8. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021 11; 78(5):e38-e50.
    View in: PubMed
    Score: 0.115
  9. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996 Mar; 27(3 Pt 2):723-8.
    View in: PubMed
    Score: 0.078
  10. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8.
    View in: PubMed
    Score: 0.072
  11. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9.
    View in: PubMed
    Score: 0.071
  12. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93.
    View in: PubMed
    Score: 0.071
  13. Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14.
    View in: PubMed
    Score: 0.069
  14. Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7.
    View in: PubMed
    Score: 0.067
  15. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90.
    View in: PubMed
    Score: 0.066
  16. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7.
    View in: PubMed
    Score: 0.065
  17. Cardiovascular risk factors, clustering and complications in overweight young men. Med Sect Proc. 1992; 107-15.
    View in: PubMed
    Score: 0.058
  18. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
    View in: PubMed
    Score: 0.057
  19. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
    View in: PubMed
    Score: 0.057
  20. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
    View in: PubMed
    Score: 0.057
  21. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol. 1991 Feb 01; 67(4):248-52.
    View in: PubMed
    Score: 0.055
  22. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34.
    View in: PubMed
    Score: 0.055
  23. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
    View in: PubMed
    Score: 0.053
  24. Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5.
    View in: PubMed
    Score: 0.050
  25. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989 Jun; 2(6 Pt 1):428-34.
    View in: PubMed
    Score: 0.049
  26. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008 Mar-Apr; 6(2):100-6.
    View in: PubMed
    Score: 0.045
  27. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care. 2005 Jun; 28(6):1487-9.
    View in: PubMed
    Score: 0.037
  28. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep. 2003 Jun; 5(3):247-54.
    View in: PubMed
    Score: 0.032
  29. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21.
    View in: PubMed
    Score: 0.030
  30. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5.
    View in: PubMed
    Score: 0.024
  31. Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96.
    View in: PubMed
    Score: 0.023
  32. Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr. 1997 02; 65(2 Suppl):671S-677S.
    View in: PubMed
    Score: 0.021
  33. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
    View in: PubMed
    Score: 0.020
  34. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015 Sep 01; 66(9):1050-67.
    View in: PubMed
    Score: 0.019
  35. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92.
    View in: PubMed
    Score: 0.019
  36. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health. 2008 Jan; 98(1):63-6.
    View in: PubMed
    Score: 0.011
  37. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
    View in: PubMed
    Score: 0.010
  38. Nutritional and lifestyle approaches to the prevention and management of hypertension. Compr Ther. 1985 Aug; 11(8):15-20.
    View in: PubMed
    Score: 0.009
  39. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension. 2004 Feb; 43(2):358-63.
    View in: PubMed
    Score: 0.008
  40. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.